Georgetown U; Lombardi Comp Can — Washington D.C., District of Columbia

Georgetown U; Lombardi Comp Can is a clinical research site located in Washington D.C., District of Columbia, United States 20016-1468.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

Georgetown U; Lombardi Comp Can has participated in 2 clinical trials.

Therapeutic areas: Renal Cell Carcinoma.

Sponsors: Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Georgetown U; Lombardi Comp Can?

Georgetown U; Lombardi Comp Can has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Georgetown U; Lombardi Comp Can conducted?

Georgetown U; Lombardi Comp Can has 2 clinical trials on record. Their work covers Renal Cell Carcinoma.

Is Georgetown U; Lombardi Comp Can accredited by Crixeo Health?

Georgetown U; Lombardi Comp Can has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Georgetown U; Lombardi Comp Can?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.